CLINICAL_TRIALS
trial_result
· 2024-07-10
Clinical Trial Update: Mast Cells in Acid-induced Intestinal Permeability [Phase 4]
Summary
A Phase 4 clinical trial investigating the role of mast cells in acid-induced intestinal permeability for dyspepsia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Dyspepsia | Phase 4 | Status: TERMINATED